Sun Pharma Looking For Acquisitions
  • Elizabeth George
  • Oct 10 2013

October 10: At a time when Indian pharma companies are struggling to address regulatory warnings on good manufacturing practices, Sun Pharma is witnessing unparalleled growth. Billionaire Managing Director Dilip Shanghvi confirms that Asia’s largest drugmaker by market value is eyeing new deals even as its rivals flounder. Bloomberg's Ketaki Gokhale discusses the company’s expansion plans and moves to accelerate growth.